chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Temperature was a little elevated; Developed a rash in my arm; Pain in my shoulder; Headache; Joint pain; A spontaneous report was received from a consumer concerning a 43-years-old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events rash in arm (injection site rash), pain in shoulder (shoulder pain), headache, joint pain (shoulder pain) and temperature was a little elevated (temperature elevation).  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 20 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (Batch Number: 032L20A) in the left arm for prophylaxis of COVID-19 infection.  On 29 Jan 2021, the patient developed rash in arm, pain in my shoulder, headache and joint pain. On 01 Feb 2021, the patient experienced temperature was a little elevated.  Treatment details included Ibuprofen.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the events, rash in arm, pain in shoulder, headache, joint pain and temperature was a little elevated was not reported.; Reporter's Comments: Based on the information provided, a strong temporal association and the established safety profile of mRNA-1273 vaccine, a causal association between the reported events and the product use cannot be excluded. The reported events are consistent with the known safety profile of the vaccine
he had monoclonal antibodies 12/10/20, he didn't report this at the time of his first Moderna dose.  Prior to receiving dose 2, he noted the MAB therapy of 12/10.  He had no symptoms or adverse events with the first dose.
PATIENT CALLED THE PHARMACY THE DAY AFTER IN INJECTION. HE SAID HIS ARM WAS VERY INFLAMED AND WONDERED IF THERE WAS AN INTERACTION BETWEEN HIS NEW CANCER DRUG, ERLEADA, AND THE FLU SHOT. OUR SOFTWARE WAS UNABLE TO CHECK INTERACTION OF FLUZONE HD WITH THIS NEW CANCER DRUG. I CALLED THE PATIENT ON 10/3/18 AND HE WAS FINE. HE SAID EVERYTHING HAD RESOLVED WITHIN 24-36 HOURS. HE DID NOT SEEK MEDICAL ATTENTION OR TAKE ANY OTC MEDS.
On the eight day after I received the Moderna Vaccine, the injection site (left arm) started to develop rashes and was very itchy that lasted for 7 days.
Discharge Diagnosis:  Principal Problem:   Acute renal failure with acute tubular necrosis superimposed on stage 2 chronic kidney disease Active Problems:   Diabetes mellitus type 2, controlled   Hypokalemia   COVID-19 virus infection   Essential hypertension     Hospital Course:  91 year old male with DM was admitted with AKI and Covid-19 infection. He had previously received vaccine booster. He was treated with Remdesivir. Renal function improved with IV fluids. He was discharged home today in stable condition. Patient educated on appropriate level of care post-discharge. Follow up with Primary Care Doctor in 5-7 days.   Physical Exam on the day of discharge: Last Recorded Vital Signs: Temp: 97.5 °F (36.4 °C) Heart Rate (Monitor): 67 Pulse: 76 BP: 152/68 Respirations: 18 SpO2: 100 % O2 Flow Rate (l/min): 0 l/min General Appearance: no distress  Eyes: PERRLA ENT: moist mucus membranes, no adenopathy Lungs: clear to auscultation bilaterally  Heart: regular rate and rhythm Abdomen: soft, non-tender  Skin: No rashes or lesions  Extremities: full ROM Neuro: alert, normal strength and tone    Consults:  IP CONSULT TO SOCIAL WORK   Significant Diagnostic Studies:   CXRF   Operations: none   Disposition:  Home    Discharge Condition:  Fair
In January 2023 I presented with shortness of breath and unable to take a full breath. I then had reflux symptoms with upset stomach. I had pain from my wrist up to my shoulders and around to my other wrist. I was weak and felt flu-like. I went to the emergency room. The initial treatment was nitroglycerin and blood pressure stabilizing drug. I was admitted to the hospital after being diagnosed with coronary dysfunction because my heart was not functioning properly. I was placed on heart monitors and had an angiogram. They implanted a stint into one of my arteries. After I was released from the hospital, I had followed up appointments with a cardiologist and other health care professionals along with cardiovascular rehabilitation. I was prescribed a one year long drug regimen.
Hospitalized 10/4/2021; COVID-19 Positive 10/04/2021; fully vaccinated  CHIEF COMPLAINT: COVID-19     Assessment/Plan   HISTORY OF PRESENT ILLNESS: Pt is a 91 y.o. male who presented yesterday for evaluation of shortness of breath, fatigue and poor po intake. He was treated for pneumonia in September but recovered from that infection with antibiotics. He had several weeks of feeling well before starting to feel symptoms again the past week (not sure of date). Has family recently diagnosed with covid as well. Follows with cardiology for CHF and valvular heart disease.    In the ER, Pt was hypoxic on RA. He required o2 via NC. Labs showed an elevated BNP, hyperkalemia, his known CKD and an elevated troponin. COVID-19 was positive. Chest xray showed CHF with a moderate right pleural effusion. He was started on Decadron and lasix with significant improvement. Initially, we did not have beds to accept him so he was pending transfer but was later admitted to HCF. Denies chest pain. Afebrile.  Care Management note 10/6/2021: Plan/Reassessment: Plan Discharge Coordination/Progress: Pt plans to return home with family supports. He denies need for further services Plan: return home. Patient-Specific Goals (Include Timeframe): return home 1-2 days
Nurse administering vaccine felt resistance while placing the needle into right deltoid. Immediately following injection, pt reported discomfort. The discomfort did not go away over days and weeks, likely vaccine was not placed in deltoid muscle. Pt has since had a steroid injection to the right shoulder which helped significantly.
swelling Narrative:  severe painful swelling of submandibular node/gland and parotid glad left side of face.  Other Relevant History:
right arm discomfort; eyelids became heavy; small slits of eyes; brow was brought down; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOMFORT (right arm discomfort), ASTHENOPIA (eyelids became heavy), OCULAR DISCOMFORT (small slits of eyes) and FACIAL DISCOMFORT (brow was brought down) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20-2A) for COVID-19 vaccination.     The patient's past medical history included Scar. Previously administered products included for an unreported indication: JUVEDERM. Concurrent medical conditions included Drug allergy, Drug allergy, Drug allergy, Seasonal allergy and Complex regional pain syndrome Type II (affects left arm). Concomitant products included POTASSIUM, PROPRANOLOL, LISDEXAMFETAMINE MESILATE (VYVANSE), VITAMIN D NOS and FLUTICASONE PROPIONATE (FLONASE ALLERGY RELIEF) for an unknown indication.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 14-Jan-2021, the patient experienced VACCINATION SITE DISCOMFORT (right arm discomfort), ASTHENOPIA (eyelids became heavy), OCULAR DISCOMFORT (small slits of eyes) and FACIAL DISCOMFORT (brow was brought down). On 14-Jan-2021, VACCINATION SITE DISCOMFORT (right arm discomfort), ASTHENOPIA (eyelids became heavy), OCULAR DISCOMFORT (small slits of eyes) and FACIAL DISCOMFORT (brow was brought down) had resolved.            Treatment information was not provided.   This case was linked to MODERNATX, INC.-MOD-2021-029855 (E2B Linked Report).; Sender's Comments:  MODERNATX, INC.-MOD-2021-029855:
Side effects like the flu; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of influenza like illness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced influenza like illness (Verbatim: Side effects like the flu). The outcome of the influenza like illness was recovered/resolved.   It was unknown if the reporter considered the influenza like illness to be related to Shingles vaccine.  It was unknown if the company considered the influenza like illness to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 10-MAR-2023 This case was reported by a patient via interactive digital media. The patient stated that the side effects to him/her like he/she had the flu for couple of days. The follow up would not possible as no contact details were available.
Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Allergic: Itch Generalized-Medium, Systemic: Body Aches Generalized-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Fever-Medium, Additional Details: Pt came into the pharmacy after receiving the vaccine on 2/1 with a localized reaction.  Itching, swollen area about 2 inches below the injeciton site.  Pt is flushed, has fatigue, fever and does not feel well.  I instructed her to ice the area, take benadryl and ibuprofen and to monitor area for worsening of symptoms.  Also to seek medical attention if airway is compromised.
broke out w/hives approx 2hr p/vax;given DPH;hives cont off & on for 3 days;
felt weird and very odd. It fell like something rolled out.; got the 2nd dose of the vaccine yesterday and the needle did not hurt but they put the needle in and something in her arm rolled; This is a spontaneous report from a contactable consumer or other non hcp. A 64-years-old female patient received second dose  bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EN6204, Expiry date not reported) via an unspecified route of administration(Age at vaccination was 64-years) in Arm Left on 25Mar2021 10:20 as DOSE 2, single for covid-19 immunisation patient didn't receive other vaccinations with in 4weeks prior to vaccinations. Historical vaccination was reported as first dose (BNT162B2, Solution for injection, Batch/Lot Number: lot EN6203, Expiry date not reported) via an unspecified route of administration, in Arm Left on 04 Mar2021 10:20 asDOSE1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported No relevant tests were reported. On 25Mar2021 the patient experienced felt weird and very odd. it fell like something rolled out, got the 2nd dose of the vaccine and the needle did not hurt but they put the needle in and something in her arm rolled patient stated to make sure the second dose of vaccination went into her arm. The patient received both doses of the Pfizer vaccine. The first was fine. The second dose felt weird and very odd. It fell like something rolled out and inquired how can she verify if it is in her and what if the vaccine did not get into the muscle.she had no symptoms afterwards and did not have a sore arm and had nothing. Caller states is the vaccine going to be in her system because it felt so weird; states after the first dose she felt fine but with the second dose she felt weird and the needle didn't hurt.Caller states she could feel the first dose and could feel a muscle ache and did not that with the second dose of the vaccine and asked did it go in there or is lost somewhere in translation or if the needle went in did she get the dose. Caller states her age at the time of the muscle soreness after the 1st dose of the vaccine was age 64 and it was three weeks ago. States she had muscle soreness the same day that she got the 1st dose of the vaccine but the muscle soreness was gone by the next day and she did not require treatment.Caller states she was on other medications but they are not to do with this and declined to provide her medications.states she wants to make sure the 2nd dose of the Pfizer Vaccine went into her arm.Caller states she wants a side effect with the second dose of the Pfizer Vaccine; states she did not get any side effects with the second dose and after the first dose she was fine. The patient didn't visited the emergency room or physician office. No investigation was done. The outcome of the events feeling abnormal and vaccination site anaesthesia was unknown.  No follow-up attempts are possible. No further information is expected.
1st Dose:  No problem; just a bit of fatigue 1 day following inoculation. 2nd Dose:  My shot was scheduled for 3:40 PM, but probably didn't receive until 4:20 PM.  At night, I had insomnia.  The next morning, my fever went up to 101.2, I had swelling of the neck, my arm @ injection site, swollen lymph nodes in my left armpit, body aches, occasional stabbing pains in random places (back, arm, leg, etc.), extreme fatigue, it lasted for 1.5 days and then the fever dropped to 99.  By the second day the fever was gone, body aches gone & only thing left on day 2 is swollen lymph nodes in arm pit, arm soreness at inoculation site, and fatigue.  Day 3 slight fatigue, a bit of soreness in arm and armpit.
red swollen area size of tennis ball around shot areas. Mostly around area where flu shot would have been given. Noticed redness and swelling approx 2 days later. Resolved without meds other than mother applied Bacitracin x 1.
Patient did not receive second dose of the Moderna COVID-19 vaccine, first dose was received in March 2021.; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Patient did not receive second dose of the Moderna COVID-19 vaccine, first dose was received in March 2021.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient did not receive second dose of the Moderna COVID-19 vaccine, first dose was received in March 2021.). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Patient did not receive second dose of the Moderna COVID-19 vaccine, first dose was received in March 2021.) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient received the first dose in Mar-2021.  No concomitant medications were reported.  No treatment medications were reported.
Lymph nodes in the right side of her neck got really tender; Lymph nodes in the right side of her neck got swo; Injection site has a big red area like a big bruise but just red; Injection site a little tender; Little swelling in the arm; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Little swelling in the arm), TENDERNESS (Lymph nodes in the right side of her neck got really tender), LYMPHADENOPATHY (Lymph nodes in the right side of her neck got swo), VACCINATION SITE ERYTHEMA (Injection site has a big red area like a big bruise but just red) and VACCINATION SITE PAIN (Injection site a little tender) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced PERIPHERAL SWELLING (Little swelling in the arm). On 29-Mar-2021, the patient experienced TENDERNESS (Lymph nodes in the right side of her neck got really tender), LYMPHADENOPATHY (Lymph nodes in the right side of her neck got swo), VACCINATION SITE ERYTHEMA (Injection site has a big red area like a big bruise but just red) and VACCINATION SITE PAIN (Injection site a little tender). At the time of the report, PERIPHERAL SWELLING (Little swelling in the arm), TENDERNESS (Lymph nodes in the right side of her neck got really tender), LYMPHADENOPATHY (Lymph nodes in the right side of her neck got swo), VACCINATION SITE ERYTHEMA (Injection site has a big red area like a big bruise but just red) and VACCINATION SITE PAIN (Injection site a little tender) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.
Early July, I started to feel chest pain. It was kind of isolated to where my heart would be. Shortly after that I felt pain in my upper back. I made an appt with doctor. She gave me some NSAIDS - 800 mg of Ibuprofen in case it was muscle pain. That didn't seem to do anything. I got a chest x-ray. Then in EKG. The pain went away. But the pain came back about two weeks ago - experiencing the chest pains again for several days. They have now gone away again. Need another doctor visit for a follow up EKG. October 2, 2021 - I had my booster COVID-19 vaccine - Vaccine Clinic Lot # FF8841 (left arm) ; I also got a flu shot (right arm) that same day. I got the pain after these vaccines.
I was given a fourth dose of this vaccine when it was only supposed to be 3 doses. I was supposed to receive a second dose of the Bexsero vaccine. I was not notified by the facility of this mistake and only realized it when completing records for my college. I am now too far removed from the first dose of the Bexsero vaccine to take my second dose. This facility has all of my medical records, is my primary care office, and knew that I was supposed to receive a second dose of Bexsero. They do not have the lot number of dose number for my fourth HPV vaccine. They should not be able to administer vaccines to the public because of their negligence.
Dizzy; Had pink dots on my chest, my breast, my forearm, my upper arm both left and right; There were lots of dots; Really tired; my head is not clear; This is a spontaneous report from a contactable consumer (patient). A 78-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EL9267), via an unspecified route of administration on an unspecified date at the age of 78-year-old as dose 1 single for covid-19 immunisation. Medical history included o Mar2020 patient had mild case of Covid and  quarantined for 1 month, she had the major symptom was fatigue, really tired and did not wanted to do anything . Concomitant medications included metoprolol succinate (TOPROL XL) taken, once in the morning and once in the evening, levothyroxine sodium (SYNTHROID) taken once a day and  lovastatin (LOVASTATIN) taken, once a day  for an unspecified indication, start and stop date were not reported. On unspecified date, few minutes after the receiving vaccine she felt dizzy and it was not severe, so she did not say anything to, was in the waiting room where everybody was waiting for 15 minutes and did not mention it because it was not severe and then drove home which was an additional 15-20 minutes and decided to take a shower. Patient had pink dots on my chest, breast, forearm, upper arm both left and right. She also experienced being really tired and head was not clear. The patient wanted to know since the effects were not severe. So, basically, are there other people receiving the same reaction or if she go for dose two and Last March she had a case of Covid, so she also wants to know how that impact if the body had already made antibody protection, does that affect getting a vaccine. The patient did not receive any treatment in response to the events.  The outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
Lymph nodes in arm were sore; Arm sore/Site of shot sore; Fever; Chills/Shivering very hard; Nausea; Headache; Fever broke twice and the 2nd time it broke, she ended up wetting the bed; Felt so sick/Sick for 2 days; A spontaneous report was received from a consumer concerning a 62 year old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced vaccination site lymphadenopathy, vaccination site pain, pyrexia, chills, headache, nausea ,vaccination complication, hyperhidrosis.  The patient's medical history was COVID-19 in Sep 2020.  Concomitant medications were metoprolol, lisinopril, bumetidine, amlodipine, potassium chloride, Synthroid ,baby aspirin ,vitamins and supplements.  On 13-jan-2021 prior to the onset of events, the  patient received her first of two planned doses of mRNA-1273(Batch Number 011J20A) on left arm in intramuscular route for COVID-19 infection.  On 13-jan-2021 the patient experienced arm was so sore, fever, chills, headache, lymph nodes on my arm were sore, site of the shot was sore, was in bed for 2 days, fever broke twice, and 2nd time I ended up wetting the bed, shivering so hard, sick for 2 days.  Treatment taken was Ibuprofen, Tylenol. Action taken with mRNA-1273 in response to the events was not reported.  On 15-jan-2021 the outcome of all events were Resolved/recovered.
Mom noticed he had hives / whelps to right cheek on his face, right arm/shoulder, and right leg.  She put child in bathtub & called the doctor on call.  Was instructed to give BENADRYL.  No redness or swelling @ injection site.
Muscle neck and right arm became very tight and knee joints hurt started at 8 pm one day after .. My wife systems much worse fever, breathing Nausea headache. this lasted for two days no energy confusion sweats
C/o soreness, redness at inj. site.  C/o tingling both R & L buttock 1 wk after Inj.
lots of heat coming out; it also itched; big fat swollen arm; red; pretty hard; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (lots of heat coming out), PRURITUS (it also itched), SWELLING (big fat swollen arm), INJECTION SITE ERYTHEMA (red) and VACCINATION SITE SWELLING (pretty hard) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included blood pressure med for Blood pressure, cholesterol med for Cholesterol, ERGOCALCIFEROL, RETINOL PALMITATE (VITAMINS A & D) for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, the patient experienced INJECTION SITE WARMTH (lots of heat coming out), PRURITUS (it also itched), SWELLING (big fat swollen arm), INJECTION SITE ERYTHEMA (red) and VACCINATION SITE SWELLING (pretty hard). The patient was treated with NAPROXEN at an unspecified dose and frequency. At the time of the report, INJECTION SITE WARMTH (lots of heat coming out), PRURITUS (it also itched), SWELLING (big fat swollen arm), INJECTION SITE ERYTHEMA (red) and VACCINATION SITE SWELLING (pretty hard) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details also included anti itch cream.